Postoperative antibiotic therapy of cervical lymphadenitis caused by nontuberculous, atypical mycobacteria;Die postoperative antibiotische therapie von zervikalen lymph-adenitiden durch nichttuberkulose, atypische mykobakterien

Laryngo- Rhino- Otologie

Volumn 78, Issue 8, 1999, Pages 450-454

  Jackel M C ^a   Witt, O ^a   Eber, S W ^a   Eiffert, H ^b   Laskawi, R ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Antibiotic therapy; Cervical lymphadenitis; Nontuberculous mycobacteria; Surgery

Indexed keywords

ANTIBIOTIC AGENT; CLARITHROMYCIN; PROTIONAMIDE; RIFABUTIN;

ANTIBIOTIC THERAPY; ARTICLE; ATYPICAL MYCOBACTERIUM; CASE REPORT; CERVICAL LYMPH NODE; CHILD; FEMALE; HUMAN; LEUKOPENIA; LYMPHADENECTOMY; LYMPHADENITIS; MALE; MINIMAL RESIDUAL DISEASE; MYCOBACTERIOSIS; ORAL DRUG ADMINISTRATION; POSTOPERATIVE CARE; PRIORITY JOURNAL;

EID: 0032862969     PISSN: 09358943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996907     Document Type: Article

References (21)

1. Benson CA. Disease due to the mycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome. Clin Infect Dis 1994; 18: 218-222
2. Benson CA. Treatment of disseminated disease due to mycobacterium avium complex in patients with AIDS. Clin Infect Dis 1994; 18: 237-242
3. Berger C, Pfyffer GE, Nadal D. Treatment of nontuberculous mycobacterial lymphadenitis with clarithromycin plus rifabutin. J Pediatr 1996; 128: 383-386
4. Byrne SK, Geddes GL, Isaac-Renton JL, Black WA. Comparison of in-vitro antimicrobial susceptibilities of mycobacterium avium-mycobacterium intracellulare strains from patients with AIDS, without AIDS and from animal sources. Antimicrob Agents Chemother 1985; 28: 440-441
5. David HL. Basis for the lack of drug susceptibility of atypical mycobacteria. Rev Infect Dis 1981; 3: 878-884
6. Falkinham JO. Epidemioloy of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1996; 9: 177-215
7. Grange JM, Yates MD, Pozniak A. Bacteriologically confirmed non-tuberculous mycobacterial lymphadenitis in south east England: a recent increase in the number of cases. Arch Dis Child 1995; 72: 516-517
8. Horsburgh CR. Advances in the prevention and treatment of mycobacterium avium disease. New Engl J Med 1996; 335: 428-429
9. Huebner RE, Schein MF, Cauthen GM, Geiter LJ, Selin MJ, Good RC, O'Brien RJ. Evaluation of the clinical usefulness of mycobacterial skin test antigens in adults with pulmonary mycobacterioses. Amer Rev Respir Dis 1992; 145: 1160-1166
10. Kentrup H, Biesterfeld S, Haase G. Nichttuberkulöse Mykobakterien als Ursache zervikaler Lymphadenitiden im Kindesalter. Dt Ärztebl 1997; 94: A-2416-A-2419
11. Kuth G, Lamprecht J, Haase G. Cervical lymphadenitis due to mycobacteria other than tuberculosis - an emerging problem in children? Oto-Rhino-Laryngol 1995; 57: 36-38
12. Kuze F, Kurasawa T, Bando K, Lee Y, Maekawa N. In vitro and in vivo susceptibility of atypical mycobacteria to various drugs. Rev Infect Dis 1981; 3: 885-897
13. Lai KK, Stottmeier KD, Sherman IH, McCabe WR. Mycobacterial cervical lymphadenopathy - relation of ethiologic agents to age. J Amer Med Ass 1984; 251: 1286-1288
14. Losurdo G, Castagnola E, Cristina E, Tasso L, Toma P, Buffa R, Giacchino R. Cervical lymphadenitis caused by nontuberculous mycobacteria in immunocompetent children: clinical and therapeutic experience. Head Neck 1998; 20: 245-249
15. Pinder SE, Colville A. Mycobacterial cervical lymphadenitis in children: can histological assessment help differentiate infections caused by non-tuberculous mycobacteria from mycobacterium tuberculosis? Histopathology 1993; 22: 59-64
16. Schaad UB, Votteler TP, McCracken GH, Nelson JD. Management of atypical mycobacterial lymphadenitis in childhood: a review based on 380 cases. J Pediatr 1979; 95: 356-360
17. Stone AB, Schelonka RL, Drehnen DM, McMahon DP, Ascher DP. Disseminated mycobacterium avium complex in non-human immunodeficiency virus-infected pediatric patients. Pediatr Infect Dis 1992; 11: 960-964
18. Sullam PM, Gordin FM, Wynne BA. Rifabutin treatment group. Efficacy of rifabutin in the treatment of disseminated infection due to mycobacterium avium complex. Clin Infect Dis 1994; 19: 84-86
19. Wallace RJ, O'Brien R, Glassroth J, Raleigh J, Dutt A. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Ann Rev Respir Dis 1990; 142: 940-953
20. Wolinsky E. Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 1995; 20: 954-963
21. Woods GL, Washington JA. Mycobacteria other than mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis 1987; 9: 275-294